menu ☰
menu ˟

Post-market trial of self-expanding TAVR system begun

14 Oct 2017
Medtronic announced a post-market clinical trial of longer-term performance for its self-expanding transcatheter aortic valve replacement system designed to improve valve sealing performance.The valve (CoreValve Evolut PRO) was recently approved in E...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.